For some considerable time now, I have been deeply interested in lasers and the development of a laser ophthalmoscope. The pathological effect of light on the ocular tissues and the value of light as a means of ocular therapy has been recognized for a long time. I propose to review the incidents leading to the use of light as a means of therapy, and ultimately to the use of this particular form oflight, i.e. laser light.
It has been known for hundreds of years that if one looked directly at the sun, the vision would be seriously affected. Constantine VII, who lived in the early tenth century, is said to have lost the sight of both eyes after looking at an eclipse, and Galileo, the great astronomer, also went blind in one eye after looking at the sun a few months before he died in 1637. It was not, however, until the seventeenth century that the central scotoma which resulted from solar burns was first described by Theophilus Bonetus of Geneva.
The first description of a solar accident in this country was by Reid (1819) , who was Professor of Moral Philosophy at Glasgow. He reported a personal accident which occurred in 1761 while he was making an exact meridian in order to observe the transit of Venus. He directed the cross hairs of a small telescope to the sun with his right eye and the sight of this eye became dim. For many weeks, if he was in the dark, or if he shut his eyes, he saw a lucid spot with the right eye. He did, in fact, inadvertently use his telescope as a retinal coagulator and he described in great detail its clinical effect almost two centuries before Meyer-Schwickerath set about producing a solar retinal coagulator.
Numerous cases of eclipse burn were reported in those days, particularly in the German literature, and after von Helmholtz invented the ophthalmoscope in 1851 descriptions of the changes occurring in the fundus accompanied the reports. As far as I can gather the first recorded description was that of Coccius who described it in his book in 1853, but the earliest accurate clinical report was by Dufour, grandfather of the present Professor Dufour of Lausanne, in 1879. He reported the case of a young man who had been blind in his left eye from childhood and who, on July 19, 1879, observed the eclipse of the sun. He developed a mist in the centre of the field of vision of his remaining eye. Dufour examined him four days after the event and found a central scotoma which he calculated was about twice the size of the image of the sun on the retina. He observed capillary hyper&mia of the macula lutea with a well defined central white spot. His treatment was to bleed the patient and keep him in a darkened room. The ophthalmoscopic signs disappeared in eleven days and the vision improved so that after three weeks it was 'half ofthe normal focus'.
Dufour attributed the changes which he observed clinically to physiological processes initiated by the illumination of the retina, but his arguments were not accepted and Czerny's animal experiments of 1867 were cited as proof of the changes being pathological. Histological examination revealed an exudative inflammation in the retina and choroid resulting finally in atrophy with pigmentation of the retina at the affected spot, and complete atrophy of the choroid. Czerny also claimed to prove experimentally that the changes were due to the light rays and not heat rays.
After the eclipse of May 17, 1882, Haab (1882), Deutschmann (1882) and Sulzer (1883) all reported cases of blindness, and in 1883 Marcus Gunn abstracted Sulzer's report for the London Medical Record. These observations sparked off various investigations into the effect of light as a therapeutic agent on the eye. As long ago as 1867 Czerny used a concave mirror 114 mm in diameter with a focal length of 192 mm and a convex lens of 30 mm in diameter with a focal length of 31 mm, arranged so that their focal lengths coincided, thus producing a parallel beam of sunlight as it passed through the dilated pupil of the experimental animal. He made various modifications to the nature of the incident light, such as removing the infra-red rays by a thick layer of water, to study their varying effects. Czerny concluded from these experiments that the changes which he had observed were the result of coagulation of the albumin which was caused by a heat generation produced by absorption of the luminous rays. Deutschmann repeated these experiments in 1882 and agreed with Czerny's findings. Widmark, in 1893, used an ultra-violet light filtered system: a 1,200 candlepower light source filtered through an oil of vitriol solution in a concave lens. It took two to four hours exposure to produce a lesion with this instrument. The resulting beam after such filtration had a minimal heat energy and produced at its focus no more than a five degree rise in temperature. He thought it was almost certain that his experiments produced a heat coagulation, but wrote: 'One could ask whether the changes which came about in human retinas as a result of sun blinding have their seat in heat coagulation.'
In his quest for the precise cause of the retinal lesions, Widmark varied his light source and used .combined zinc and carbon arc rods as well as sunlight focused by a heliostat. He noted the different results with red and yellow or blue and violet rays. He concluded: 'One could feel inclined to give those rays which were most refractile the most significance' and he assigned the therapeutic effects to the short wavelengths.
The practical use of light as a therapeutic measure is more recent and is a result of Meyer-Schwickerath's work (1960) . This stemmed from his observations of macular damage following the eclipse of July 10, 1945. He started his experiments the following year and his first clinical instrument used the sun as the source of light. He used a heliostat and a mirror to reflect the sun's rays through a Galilean telescope and so into the eye via an indirect ophthalmoscope mounted on a universal joint.
Meyer-Schwickerath soon abandoned the use of sunlight and turned to artificial sources of light. The final instrument, which he and Dr Littman of Carl Zeiss designed, uses a high powered xenon lamp and the light from this source is filtered through lenses with suitable refractive properties allowing only cold light to emerge. Hence the clear media of the eye transmit the light without sustaining actinic damage.
This work of Meyer-Schwickerath established the unquestionable value of light in the treatment of detachment of the retina. It is one of the big milestones of progress and Meyer-Schwickerath's name must take its place in the annals of detachment surgery with those of Gonin, Guist and Arruga. His introduction of light therapy also pioneered the prophylactic treatment of the second eye and made it possible to prevent many catastrophes. Professor Einstein's theoretical studies of stimulated emission of radiation (1917) marked the beginning of the work which eventually resulted in the production of a maser and very soon after of a laser.
In 1951, Townes, who was particularly interested in microwaves, thought of imitating nature and using atoms to generate electromagnetic waves. In 1953 he produced, with Gordon and Zeiger (1954), a microwave generator and called it a maser (Microwave Amplification by the Stimulated Emission of Radiation). The following year two Russians, Basov and Prokhorov (1954) produced a somewhat similar ammonia gas maser.
Six years later Maiman (1960a, b) produced the first laser. Using an artificial ruby rod with parallel silvered ends, he produced short bursts of intense red light. This light was different from anything which had been seen before. It was coherent and very pure. It was virtually monochromatic of 6943 A, in phase and of a single amplitude. The beam was almost parallel, unlike a beam from any other source of light. It was soon realized that this new form of light had immense possibilities, particularly in medicine. It was not long before experiments to adapt it to ophthalmic treatment commenced in America. Since then, great strides have been made and more than one ophthalmic laser has appeared.
Our own work (Ingram 1964 , Ingram et al. 1965 commenced in 1963 with a very crude bench apparatus. The laser weighed 13 lb and to the end of this we attached an old ophthalmoscope head from which we had removed the condensing lens. The laser beam was reflected into the eye by the mirror and observed through its central aperture. This apparatus was much too cumbersome and it was difficult to reflect the beam into the rabbit's eye. Nevertheless, it served to prove that the laser beam was effective.
After these experiments the next stage was to reduce the laser cavity and the size of the ruby rod so that we were able to accommodate it in a handle about the same size as that of an ordinary ophthalmoscope. The laser cavity is elliptical and made of highly polished aluminium. The instrument was now very similar in size and weight to a standard direct ophthalmoscope, but was still very much of a crude prototype. The laser beam emerged from the hole in the top of the handle and was reflected by a half mirror into the rabbit's eye. The illuminating beam came from a 3 volt bulb fixed to the front of the head. Cross hairs were taped to the front of this lamp to project a target on to the fundus. The viewing light was reflected into the eye by the mirror, through which the observer looked, as in an ordinary direct ophthalmoscope.
The present model of the ophthalmoscope (Fig 1) , as a clinical instrument, is much more powerful and effective than the model which was demonstrated at Oxford in July 1964. It contains two optical systems, for the laser and illuminating beams. We have avoided dichroic mirrors and shutters. We consider dichroic mirrors are a potential danger because they may transmit a percentage of the laser beam. It can be seen from the optical diagram (Fig 2) that the laser beam is passed through a telescopic lens system to reduce its diameter from a quarter to an eighth of an inch and is then reflected by a three mirror system into the eye of the animal or patient. The illuminating beam is provided by a 6 volt lamp and is made divergent by a lens system. The target is inserted in this beam and is focused on the retina at the point of impact of the laser beam. All lenses and mirrors in the path of the laser beam must be worked to a very high optical finish to avoid upsetting the coherence of the beam.
The power pack consists of a bank of high voltage capacitors which can be connected together to give various energy inputs from 320 joules to 980 joules. The output of this range is 0-052 joule to 0-375 joule. The discharge of these capacitors is initiated by a high voltage trigger pulse of about 7,500 volts to a wire wound round the flash tube in the laser cavity. A powerful fan is built into the pack and cold air is blown into the handle of the instrument. This provides adequate cooling so that the firing repetition rate is about 4 seconds with the lower energies. This rises a little with higher output energies. Audible warning is given when the capacitors are recharged and ready for firing. Various safety devices are incorporated. When the cover of the control panel is opened the instrument cannot be fired. A foot switch is also provided and when this is plugged in it is impossible to fire the instrument by the microswitch on the handle unless the foot switch is also depressed. Also it cannot be fired by the foot switch only; the microswitch must also be operated. A dial is provided so that the number of applications possible can be predetermined. The maximum setting is 20 and it must then be reset.
A filter has also been incorporated to prevent any laser light being reflected back into the observer's eye.
Treatment
In treating an eye it is essential to have the pupil maximally dilated with 10% phenylephrine hydrochloride and 2 % cyclopentolate and to avoid applying the beam to the iris.
The actual application only lasts 0 0008 sec, which is much less than the human reflex reaction. Hence, if the aiming spot is in the correct position on the fundus when the microswitch is pressed, the patient cannot possibly move his eye in time to do any damage. The full energy of the beam is applied in this short space of time, unlike with the xenon arc apparatus, and the only way to vary the effect is to increase the energy or alter the spot size by defocusing the beam. Fig 3 shows lesions of various sizes all produced by the same output but with different defocusing lenses.
When applying treatment to an eye, one should commence with a low energy and gradually increase until the desired effect is obtained. Clinically, the ideal lesion seems to be accompanied by a small subretinal pearly bubble in its centre (Fig 4) . An increase in the energy produces a larger bubble, which may break through into the vitreous, or a small h2morrhage. With the present instrument this tends to occur with input energies over 560 joules. This hlemorrhage soon absorbs, often within twenty-four hours, and does not cause complications, nor does it detract from the result. Nevertheless, it is undesirable and should be avoided. Pigmentation develops quite early. A fine pigmented halo is often seen round the spot within a few minutes of the application, as if a drop of water had fallen on to a dusty plate, pushing the dust aside. This is probably due to disruption of the pigment epithelial cells releasing the pigment granules which are pushed aside by the explosive lesion. The bubble, which is probably carbon dioxide and steam, absorbs very quickly and has usually disappeared within three or four minutes of treatment. Pigmentation is more obvious in twenty-four hours and often well marked in four days. The final lesion is a pigmented spot, surrounded by a halo of chorioretinal atrophy.
Mode ofAction
Our work in Newcastle has led us to believe that the laser beam does not produce its effect by conversion of the energy into heat, causing coagulation of the proteins, as with light coagulation resulting from exposure to the xenon arc.
Early in our experimental work we measured with a chromel alumel thermocouple inserted between the retina and choroid the heat produced in the retina by the laser beam. We found only an insignificant rise, localized to the area treated.
We have also compared the temperature changes inside the eye after treatment with the ruby laser and the xenon arc coagulator.
With a thermocouple inserted into the anterior chamber just in front of the iris, the eye was exposed to doses of 25 joules non-Q-switched and 2 joules Q-switched focused by a 5 cm focal length lens at the level of the iris and anterior lens capsule. A rise of 1 5°C above body temperature was recorded. This experiment was repeated with the thermocouple inserted into the middle of the vitreous, but even here a rise of only 2°C occurred. Repeating the exposures did not produce any further rise of tissue temperature.
To measure the temperature changes produced by the xenon arc coagulator we inserted the thermocouple behind the iris and focused the beam on the anterior surface of the iris using overcharge (red) three, an iris diaphragm of 3-5 and intensity diaphragm of 0. With an exposure of 05 sec (which in a human iris causes contraction to pull down an updrawn pupil) there was a rise of 20°C. When the exposure was increased to 2-5 sec there was a rise of 104°C. This dose produced coagulation of the protein in the rabbit's aqueous.
It appears that the only heat production we get with the laser is due to acceleration of the molecular fragments in the lesion. This thermal effect is secondary to the lesion, as is emphasized by the temperature measurements I have quoted.
With the xenon arc the temperature measurements are very much higher and summation occurs, and it seems obvious that the coagulation is a heat phenomenon. Noyori et al. (1963) have made extensive studies of the thermal effects on the ocular tissues by xenon arc photocoagulation and laser applications, and they came to the conclusion that extensive heating of the vitreous in severe ametropias does not occur with the laser. They found that even rapid pulsing of the laser did not produce any build-up of temperature in the vitreous. The effect of the xenon arc was quite different and thermal summation could only be prevented by careful control of the frequency of the applications. Noyori and his colleagues suggested that this may be partly explained by the fact that heat absorption by the vitreous may be less at the wavelength of the ruby emission, but substantially greater at many of the xenon arc wavelengths, particularly the longer ones. I think this is a tenable explanation. The laser beam is coherent and produces its effect with much less energy than does the xenon arc. We have measured 14. Noyori and his collaborators found that the rise of temperature produced by the laser and the xenon arc at the actual site of treatment in the retina was essentially the same, but the duration of the rise was markedly different. In the case of the laser, the temperature fell almost immediately to its previous level and they found it virtually impossible to produce a sustained rise with repeated applications.
12-
We have always held the view that the laser lesion is really an electromagnetic disruption of the tissues at the spot where the beam is focused. This would explain the immediate clinical appearances of the lesion produced.
It is for this reason that I prefer to avoid the term photocoagulation in relation to laser phototherapy and reserve it for the phototherapy lesions produced by the xenon arc apparatus.
Intensity ofReaction
The energy output must be controlled carefully to prevent too great an explosive effect. I have already referred to the subretinal bubble which I think indicates the ideal clinical lesion. Any greater effect indicates an overdose. The breaking through of the bubble into the vitreous or the production ofeven small hemorrhages means that the energy has been too great. I will refer to this again when I deal with the effect of doses far above anything used clinically.
Protection ofthe Operator andAssistants
At no time must anyone look at the laser beam. While I do not think there is any danger of onlookers or attendants in the theatre being affected by reflected light from doses used in treatment, I am sure there is a real danger of damage ensuing from exposure to some of the higher energies which are being used increasingly in the laboratory or research department. Indeed, Rathkey (1965) reports a case of loss of macular vision. The accident occurred in February 1964 to a student who accidentally viewed a laser beam with his right eye, and he developed a permanent central scotoma and dense macular pigmentation.
Nevertheless, I think it is highly desirable for onlookers to wear protective glasses to eliminate any spectral reflection to which they may be For the operator's protection we are fitting a filter of the same glass into the ophthalmoscope.
I have no doubt that further reports of accidents willt appear in the literature from time to time, so it is essential to formulate a safety code and develop protective measures. The first essential is to study the effects of various doses on the ocular tissues and evaluate all their aspects. At the International Research and Development Company in Newcastle all the laser workers are screened very carefully before commencing. Full detailed visual examinations are made, including refraction, fields of vision and fundus examination. Any abnormality in the fundus is photographed for future reference. We exclude from laser work anyone with less than 6/12 vision in either eye. Admittedly this is on an arbitrary basis, but we feel that if he has a laser accident to his better eye and the vision of his other eye is less than 6/12 he may well be unable to carry on in a scientific occupation.
In the near future protective goggles will be issued, but it is emphasized that these are not by any means a certain protection against the hazards of laser exposures and although they seem to be able to prevent energies of up to 1 joule marking the retina experimentally, they may not do so with energies greater than this.
Indications
The indications are similar to those for light coagulation. It is equally important to have the retina in contact with the choroid in either method of treatment.
Retinal detachments which have flattened out with bed rest, holes in flat retinas and predetachment lesions, such as lattice degenerations, lend themselves ideally to laser therapy.
This form of treatment is eminently suitable for limiting the spread of retinoschisis, and for sealing off peripheral dialyses, particularly where the retina is still flat fairly well out to the periphery. It is also very valuable as an adjunct to other detachment surgery, for example, to seal off doubtful areas after diathermy, scleral resections, bucklings or scleral pocketing procedures (Fig 6) . A line of laser applications inside an encirclage operation in some cases may enable one to remove an encircling suture subsequently and so obviate the late complications which can follow (Fig 7) .
Advantages I think there are several advantages of laser therapy: (1) No anesthesia, either topical or retrobulbar, is necessary. (2) The patient experiences no pain. (3) The movements of the eye are not affected and the patient can therefore co-operate by looking in the required direction to bring the lesion into view. (4) No overheating of the clear media occurs and no complications involving cornea, lens or vitreous, have been seen even on histological section (I will refer to such complications with massive dosages later). (5) Convalescence is much shorter than with conventional light coagulation because pigmentation occurs earlier and adhesions develop more rapidly. (6) As there can be no chromatic aberration the beam is better focused at the periphery and therefore more effective. (7) Many cases, particularly those receiving prophylactic treatment, can be dealt with as outpatients. (8) Aphakic and other cases of severe ametropia can be treated without having to use a contact lens. 
Complications
Except for the smaAl retinal himorrhages already referred to, which indicate too great an energy, the only complications we have encountered have involved the iris. If the beam hits the iris instead of passing completely through the pupil, it soon produces contraction. This contraction cannot immediately be overcome by mydriatics and takes at least twenty-four hours to pass off. We have not seen any corneal or vitreous changes in any of our cases, but Campbell et al. (1965) have recently reported transient fine punctate corneal staining in 25 % of patients who had extensive laser therapy. They were not sure that this was not just the result of exposure keratitis.
Once one exceeds the range of energies which we have decided are clinically useful and of therapeutic value, the effects are disastrous and become increasingly so the more the energy is raised. In spite of the transmission curves of the ocular tissues, showing that practically the whole of the rays of the laser beam of 6943 A are transmitted by the clear media, we have shown that even the cornea and lens are affected if the dose is sufficiently high.
We have experimented with a wide range of energies from 0 05 joule to 25 joules Q-spoiled and Table 1 summarizes the results obtained. We have not yet worked out the actual energy thresholds for lesions of the cornea and lens, &c., but investigations are proceeding and will be the subject of further communications.
Group I is the therapeutic range. In every case we begin with a small dose and gradually increase until the required effect is produced. The dose required will vary with the pigmentation of the fundus and the site of the lesion. It is usually found that higher energies are necessary to treat the periphery than the central regions of the fundus. Defocusing by the insertion of a plus or a minus lens in the pathway of the laser beam enlarges the spot size on the fundus and may necessitate a higher dose than without it.
Group 2 includes dosages which are higher than those usually required, but which still do not come within the range which I term industrial. With energies of this order (05 to 1 joule) we have produced changes in the retinal vessels. In some cases instead of the subretinal bubble of the therapeutic lesions, a stream of bubbles came forward into the vitreous along the pathway of the beam. These bubbles did not rise in the vitreous as in some of the more massive lesions, but remained along the laser track as if the vitreous here was liquefied. Immediately after the bubbles came forward a haemorrhage occurred. Although this too came well forward into the vitreous it retained the appearance of a subhyaloid hmemorrhage, supporting the belief that the vitreous had become locally liquefied. There were individual variations in the resulting lesions from these doses and some produced a single large bubble only. The hemorrhages occurring with this range of energies all absorbed in a relatively short time, leaving no changes additional to the fundus lesion.
When a beam of 05 joule output was applied to an arteriovenous crossing on the tapetum close to the margin of the disc, definite vascular changes occurred. Therapeutic doses do not affect the vessels, which can be safely ignored when treating a case, but with these somewhat larger doses the following changes were observed:
(1) Both vessels became blanched and disappeared from view distal to the site of the application.
(2) Proximal to the application the vessel showed 'cattle-trucking'. (3) What appeared to be tiny hemorrhages along the line of the vessel developed. Examination of the fundus the following day revealed the true nature of these. They were small aneurysmal beads. There were no hemorrhages in the -surrounding tapetum. We have studied these changes with fluorescein photography and I think confirmed the development of aneurysms. Histological studies are waiting to be carried out.
The remaining groups in Table 1 include all the higher powered dosages and the effects produced are what we might expect to see in severe industrial accidents.
Group 3 includes a wide range from the top limit of any likely therapeutic dose up to 25 joules. Up to this limit extensive disruptive changes occur in the tunica of the posterior pole accompanied by changes in the vitreous, but the cornea remains transparent. The lens is involved with the highest doses of this group.
It will be appreciated that these beams are directed at the rabbit's eye as accurately as possible, remembering that they cannot be adjusted by direct observation. The diameter of the beam is much larger than that from the ophthalmoscope and is not, therefore, limited to the actual pupil. In none of these cases did the rabbit demonstrate any evidence of discomfort, let alone pain.
At the lower end of this group we produced gross chorioretinal changes and vitreous hmmorrhages. There was debris anterior to the lesion and a hemorrhage spurting out into the vitreous. Bubbles floated up in front of the disc carrying debris with them. The hemorrhage absorbs fairly rapidly leaving no apparent lesion other than that in the fundus.
At the higher end of this group, using energies of 25 joules we still found no evidence of corneal involvement, but there was extensive depigmentation of the iris and considerable deposition of pigment on the anterior lens capsule giving it a watermark appearance. Diffuse changes were also observed in the lens itself, but the fundus could still be seen through it. A large area of the retina and choroid had disappeared leaving a white disc like a coloboma. We thought in one case that even the sclera had disintegrated and that orbital fat was visible. This area was relatively avascular, but below it there was hwmorrhage and debris. By the following day there was some cedema of the lids and the conjunctiva was chemotic, but the cornea was still clear. The lens changes had progressed and lens matter had escaped into the anterior chamber. The fundus could no longer be seen.
Group 4: These lesions are caused by Q-switching. In these cases we used an output beam giving 2 joules when Q-switched. There are various methods of producing Q-switching, and in our early experiments we used rotating prisms. We are now using a cryptocyanine cell which enables us to obtain much higher powers. This is opaque to a ruby laser beam until the intensity reaches a certain level, when the dye in the cell bleaches and lets the light go through to the reflecting surface. We then get an enormous burst of energy and an emission of a very high power in a much smaller space of time.
We used a 0 5 inch diameter, 6 inch ruby rod giving an emerging beam of 1 sq. cm crosssection. It gives a pulse power of 70 megawatts per sq. cm for a period of 30 nano seconds (that is 30 thousandths of a millionth of a second). Unfocused, the beam diameter was 1 2 cm. This produced extensive damage to the retina, but the cornea and lens remained perfectly clear.
The effect on the iris is paradoxical and so far unexplained. A previously miotic pupil becomes widely dilated (probably due to some humoral effect either on the dilator or sphincter pupille) while a previously dilated pupil becomes miotic (probably a light reflex ofretinal origin).
Group 5: When we focus the beam with a 5 cm focal length lens the beam divergence is such as to produce a focal zone (or spot) about 1 mm in diameter. The power density in this zone is 4,000 megawatts per sq. cm. This is equivalent to the power delivered by about forty Battersea Power Stations all working together. The total output energy of this Q-switched beam is 2 joules in two pulses each of 40 megawatts, and each lasting 30 nano seconds and separated by an interval of 100 to 200 nano seconds. We had the rabbit so placed that the focal length of this lens coincided with the anterior surface of the rabbit's lens (Fig 8) . The effect was quite different from that in any of our previous experiments. An immediate lesion appeared in the cornea, lens, fundus and vitreous. The opacity in the cornea (Fig 9) was strictly localized, but extended throughout the whole depth. Initially there was the appearance of a pit on the surface, but the affected zone of the cornea soon became oedematous, leading to anteroposterior thickening. We think this was probably due to a spark just in front of the cornea where the electric field was so high that the air broke down as if it were a miniature lightning flash.
A conical lens opacity also appeared immediately, extending in a diverging beam posteriorly through the whole depth of the lens. There were glistening vacuoles in the lens at first, but they rapidly disappeared from view as the lens opacity increased. The shape is explained by the beam divergence from the focus just at the anterior surface of the lens. This also explains why the fundus lesion was correspondingly larger. The vitreous contained a large amount of debris, bubbles and hiemorrhage, making the fundus lesion extremely difficult to see. The lower part of the retina was obviously detached.
The following day the corneal changes were more extensive and there was a zone of oedema round the original focus. The anterior chamber, which showed no visible changes initially, now showed a flare. The lens opacity was now generalized and prevented any view of the fundus.
The severe changes which I have described as occurring with exposure to high energy densities have no place as yet in therapeutics, but inadver-tent exposure to such weapons will produce them and as ophthalmologists we must know what to expect. I do not think such lesions can be treated, and we must concentrate on prevention and protection. However, like Medusa's head, these devices do not constitute an intractable problem.
The known laser wavelengths and laser materials are increasing in number almost weekly and their uses are growing even more rapidly. For example, a helium-neon continuous gas laser emitting rays of 6328 A can be used for communications, spectroscopy and other forms of mensuration and it provides an ideal source of parallel rays of light. With this laser we can easily demonstrate the imperfections of optical components in a fraction of the time required by conventional methods. If we insert a good and a poor lens in the beam the difference can be observed. This is not only because the beam is monochromatic but because it is coherent. Although this type of laser has no direct relation to the subject of my address, our interest in it arises from its potential uses in rapid ocular mensuration and it may well have a useful place in ophthalmology of the future.
